← Open Payments lookup

ANIWELYN TAN: Open Payments

NPI 1477056356 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,087 in 29 payments from 13 companies in 2025. Trend: 2023 $3,086 · 2024 $2,101 · 2025 $2,087

Food & beverage: $2,087
CompanyPaymentsAmount
Amgen Inc.3$367
Dexcom, Inc.3$296
Abbott Laboratories3$286
Teva Pharmaceuticals USA, Inc.3$165
ABBVIE INC.6$164
Novo Nordisk Inc2$142
GENZYME CORPORATION1$122
Lilly USA, LLC1$122
AstraZeneca Pharmaceuticals LP1$122
Grifols USA, LLC1$116

Products named: DEXCOM G7 GSS (161), FREESTYLE LIBRE 3, KRYSTEXXA, VRAYLAR, AUSTEDO XR, Ozempic, FABRAZYME, OTEZLA.

Industry payments across TX — which companies pay providers there.